60 Degrees Presents Investor Presentation for Malaria Platform
60 Degrees Pharmaceuticals, Inc. released an investor presentation outlining its strategy for vector-borne disease therapeutics, highlighting its marketed antimalarial platform ARAKODA as a basis for future indication expansion into babesiosis.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day